why choose us

First received: May 05, 2023

Clinical Trial: A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Rheumatoid Arthritis

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open Label, 3-treatment Period, 1-sequence, Cross-over Study to Evaluate Pharmacokinetics, Safety, and Tolerability After Single Ascending Oral Doses of SAR441566 in Healthy Adult Japanese

Brief Summary: This is a cross-over, Phase 1, 3-treatment period single sequence study.The purpose of this study is to characterize pharmacokinetics (PK), safety, and tolerability of single ascending oral doses of SAR441566 in healthy male Japanese participants, 18-55 years of age.

Read more